Brand profile · Biotechnology Research

Neurizon Therapeutics Limited

Neurizon Therapeutics Limited runs a Biotechnology Research operation from Melbourne, Victoria. Publicly held, at neurizon.com. It holds one address on record, all in Australia. It employs 10 people, on the record. It lists biotechnology and pharmaceutical among its specialties. One Australian registration (ABN) is a confirmed match. The record links three similar brands, most of them in Biotechnology Research.

LinkedIn

Profile live Public Company 1 entity ABN 1 office country
Registry verified · ABR
Counted staff
10
self-reported 2–10 band
Founded
Not recorded
Legal entities
1
ABR
Office countries
1
1 of 2 reported addresses
Funding rounds
None on record
Company type
Public Company
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity

  • NEURIZON THERAPEUTICS LIMITED

    ABN35094006023

    VICHigh confidenceMatched on exact nameABR

Legal entities

Neurizon Therapeutics Limited: 1 registry entityNeurizon Therapeutics Limited is linked to 1 registry entity: NEURIZON THERAPEUTICS LIMITED (ABN 35094006023, candidate).Neurizon Therapeutics LimitedNEURIZON THERAPEUTICSLIMITEDABN 35094006023Candidate · High confidence
Show as table
NEURIZON THERAPEUTICS LIMITEDABN 35094006023
Confirmed matches0 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Neurizon Therapeutics Limited (ASX: NUZ), formerly known as PharmAust, is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease. Neurizon strategy is to accelerate access to effective ALS treatments for patients, while exploring NUZ-001’s potential for broader neurodegenerative applications. Through international collaborations and rigorous clinical programs, Neurizon is dedicated to creating new horizons for patients and families impacted by complex neural disorders.

Specialties

All 6 specialties
  • Pharmaceutical
  • Biotechnology
  • Drug manufacturing
  • Motor Neurone Disease
  • Neurodegenerative diseases
  • Amyotrophic lateral sclerosis

Locations

2 reported addresses · 1 on record.

Australiaprimary

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table
Countries1
Primary countryAU

All codes: AU

Addresses

  • AU385 Bourke Street; Suite 2, Level 11; Melbourne, Victoria 3000Primary

Grid intelligence Members

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Notify me about spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend
Notify me about signals

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
Notify me about financials

People & contacts

4 employee profiles on record · names withheld.

The people relation is never requested, so there is nothing here to unlock.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under Neurizon Therapeutics Limited?

One Victoria entity on the ABR: NEURIZON THERAPEUTICS LIMITED (ABN 35 094 006 023), high confidence.

How many people work at Neurizon Therapeutics Limited?

10 counted staff profiles at January 2026, inside the self-reported 2–10 band.

Where does Neurizon Therapeutics Limited have offices?

One address on record, Australia only. Primary: 385 Bourke Street, Suite 2, Level 11, Melbourne, Victoria 3000.

Has Neurizon Therapeutics Limited raised funding?

None linked to this brand.

What does Neurizon Therapeutics Limited list as its specialties?

Six tags on the brand's own list, among them biotechnology and pharmaceutical.

Which companies are listed alongside Neurizon Therapeutics Limited?

Three peer profiles on record: Chimeric Therapeutics and Kingsgate Consolidated Limited.